Avalo Therapeutics AVTX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's common stock shares issued?
- Avalo Therapeutics (AVTX) reported common stock shares issued of 24.6M in Q1 2026.
- How has Avalo Therapeutics's common stock shares issued changed year-over-year?
- Avalo Therapeutics's common stock shares issued increased by 127.5% year-over-year, from 10.8M to 24.6M.
- What is the long-term trend for Avalo Therapeutics's common stock shares issued?
- Over 5 years (2020 to 2025), Avalo Therapeutics's common stock shares issued has grown at a -24.4% compound annual growth rate (CAGR), from 75M to 18.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.